Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pCMV-T7-ABEmax(7.10)-SpCas9-NG-P2A-EGFP (RTW4564) Citations (2)

Originally described in: Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants.
Walton RT, Christie KA, Whittaker MN, Kleinstiver BP Science. 2020 Apr 17;368(6488):290-296. doi: 10.1126/science.aba8853. Epub 2020 Mar 26. PubMed Journal

Articles Citing pCMV-T7-ABEmax(7.10)-SpCas9-NG-P2A-EGFP (RTW4564)

Articles
Base Editing in Human Cells to Produce Single-Nucleotide-Variant Clonal Cell Lines. Vasquez CA, Cowan QT, Komor AC. Curr Protoc Mol Biol. 2020 Dec;133(1):e129. doi: 10.1002/cpmb.129. PubMed
Functional restoration of a CFTR splicing mutation through RNA delivery of CRISPR adenine base editor. Amistadi S, Maule G, Ciciani M, Ensinck MM, De Keersmaecker L, Ramalho AS, Guidone D, Buccirossi M, Galietta LJV, Carlon MS, Cereseto A. Mol Ther. 2023 Jun 7;31(6):1647-1660. doi: 10.1016/j.ymthe.2023.03.004. Epub 2023 Mar 9. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.